Public trial registry of the CCC-Munich

Trial 26866138MMY2031

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
26866138MMY2031
World
Full title
:

Klinische Prüfung zur Remissionsinduktion mit Bortezomib (Vel.), Cyclophosphamid (C) und Dexamethason (D) bei Patienten bis 60 Jahren mit unbehandeltem Multiplen Myelom und geplanter Hochdosischemotherapie: (VelCD), (DSMM XIA)

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C90.0- Multiples Myelom
Trial design
World
Trial type
:
Interventional
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Positive
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.